Completed PHASE4 INTERVENTIONAL 2-arm NCT02871908

Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial

Sponsor: Medical University of Warsaw

Conditions Antibiotic Associated Diarrhea Diarrhea

Interventions Lactobacillus reuteri DSM 17938 Placebo

Updated 6 times since 2017 Last updated: Mar 18, 2018 Started: Dec 31, 2016 Primary completion: Mar 31, 2018 Completion: Mar 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02871908, this PHASE4 trial focuses on Antibiotic Associated Diarrhea and Diarrhea and remains completed. Sponsored by Medical University of Warsaw, it has been updated 6 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Apr 2018 — Jun 2018 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Recruiting PHASE4

First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Warsaw

Data source: Medical University of Warsaw

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Warsaw, Poland